NeuroKlinika Gabinet Lekarski Prof. Andrzej Bogucki

Verified siteinfo

Poland Andrzeja Struga 49/51, 90-640 Lodz, Poland

2 trials recruiting
Parkinson's disease · Craniocerebral injury · Paresis
Adult patients

About Specializations

NeuroKlinika Gabinet Lekarski Prof. Andrzej Bogucki in Lodz, Poland specialises in clinical trials of conditions such as Parkinson's disease, Craniocerebral injury, Paresis, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology

The medical center is at the forefront of neurological research, with a particular focus on Parkinson's disease. The center is dedicated to exploring innovative treatments that enhance the quality of life for patients experiencing motor fluctuations.

Parkinson's Disease Management
Motor Function Assessment
Advanced Therapeutic Infusions

Through its pioneering work, the center is advancing the understanding of motor function in Parkinson's patients, utilizing subject-completed diaries to assess the efficacy of new treatment modalities.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Andrzeja Struga 49/5190-640 LodzPoland

Open in maps ↗

Recruiting now: 2 trials
Conditions studied: 3
Partner status: Verified site

More sites in Lodz Poland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

5 clinical trials

Craniocerebral injury

Recruiting

Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

Investigational

Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Cenegermin
Sponsor:Dompe' Farmaceutici S.p.A.

Contact Research Centre

Parkinson's disease

Recruiting

A Study Testing the Safety of IRL757 in Adults with Parkinson's Disease Who Have Apathy

Investigational

A Study Testing the Safety of IRL757 in Adults with Parkinson's Disease Who Have Apathy

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Integrative Research Laboratories Sweden AB

Contact Research Centre

Parkinson's disease

Not yet recruiting

A Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients

Investigational

A Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Paresis

Not recruiting

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
Sponsor:Merz Pharmaceuticals GmbH

Contact Research Centre

Parkinson's disease

Not recruiting

Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations

Investigational

Study on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Carbidopa
Sponsor:Neuroderm Ltd.

Contact Research Centre

Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites